List of Tables
Table 1. Global Anticancer Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anticancer Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anticancer Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anticancer Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anticancer Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anticancer Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anticancer Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anticancer Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anticancer Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anticancer Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anticancer Injection, Product Type & Application
Table 12. Global Key Manufacturers of Anticancer Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anticancer Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anticancer Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anticancer Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Anticancer Injection Sales Market Share by Region (2020-2025)
Table 19. Global Anticancer Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Anticancer Injection Sales Market Share by Region (2026-2031)
Table 21. Global Anticancer Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anticancer Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Anticancer Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anticancer Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Anticancer Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anticancer Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Anticancer Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Anticancer Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anticancer Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anticancer Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anticancer Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anticancer Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anticancer Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anticancer Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anticancer Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anticancer Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anticancer Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anticancer Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anticancer Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anticancer Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anticancer Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anticancer Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anticancer Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anticancer Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anticancer Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anticancer Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anticancer Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anticancer Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anticancer Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anticancer Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Anticancer Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Anticancer Injection Sales Market Share by Type (2020-2025)
Table 53. Global Anticancer Injection Sales Market Share by Type (2026-2031)
Table 54. Global Anticancer Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anticancer Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anticancer Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Anticancer Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Anticancer Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anticancer Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anticancer Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Anticancer Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Anticancer Injection Sales Market Share by Application (2020-2025)
Table 63. Global Anticancer Injection Sales Market Share by Application (2026-2031)
Table 64. Global Anticancer Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anticancer Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anticancer Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Anticancer Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Anticancer Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anticancer Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Roche(Genentech) Company Information
Table 71. Roche(Genentech) Description and Business Overview
Table 72. Roche(Genentech) Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche(Genentech) Anticancer Injection Product
Table 74. Roche(Genentech) Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bayer Anticancer Injection Product
Table 79. Bayer Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Anticancer Injection Product
Table 84. Novartis Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Anticancer Injection Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Amgen Company Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Amgen Anticancer Injection Product
Table 94. Amgen Recent Developments/Updates
Table 95. Mabxience Company Information
Table 96. Mabxience Description and Business Overview
Table 97. Mabxience Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Mabxience Anticancer Injection Product
Table 99. Mabxience Recent Developments/Updates
Table 100. Luoxin Pharmaceutical Company Information
Table 101. Luoxin Pharmaceutical Description and Business Overview
Table 102. Luoxin Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Luoxin Pharmaceutical Anticancer Injection Product
Table 104. Luoxin Pharmaceutical Recent Developments/Updates
Table 105. Qilu Pharmaceutical Company Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Qilu Pharmaceutical Anticancer Injection Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Company Information
Table 111. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Description and Business Overview
Table 112. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anticancer Injection Product
Table 114. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Recent Developments/Updates
Table 115. Fuxing Medicine Company Information
Table 116. Fuxing Medicine Description and Business Overview
Table 117. Fuxing Medicine Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Fuxing Medicine Anticancer Injection Product
Table 119. Fuxing Medicine Recent Developments/Updates
Table 120. Yuekang Pharmaceutical Company Information
Table 121. Yuekang Pharmaceutical Description and Business Overview
Table 122. Yuekang Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Yuekang Pharmaceutical Anticancer Injection Product
Table 124. Yuekang Pharmaceutical Recent Developments/Updates
Table 125. Yuheng Pharmaceutical Company Information
Table 126. Yuheng Pharmaceutical Description and Business Overview
Table 127. Yuheng Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Yuheng Pharmaceutical Anticancer Injection Product
Table 129. Yuheng Pharmaceutical Recent Developments/Updates
Table 130. Hengrui Medicine Company Information
Table 131. Hengrui Medicine Description and Business Overview
Table 132. Hengrui Medicine Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Hengrui Medicine Anticancer Injection Product
Table 134. Hengrui Medicine Recent Developments/Updates
Table 135. Huiyu Pharmaceutical Company Information
Table 136. Huiyu Pharmaceutical Description and Business Overview
Table 137. Huiyu Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Huiyu Pharmaceutical Anticancer Injection Product
Table 139. Huiyu Pharmaceutical Recent Developments/Updates
Table 140. Changbaishan Pharmaceutical Co., Ltd. Company Information
Table 141. Changbaishan Pharmaceutical Co., Ltd. Description and Business Overview
Table 142. Changbaishan Pharmaceutical Co., Ltd. Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Changbaishan Pharmaceutical Co., Ltd. Anticancer Injection Product
Table 144. Changbaishan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 145. Innovent Biologics (Suzhou) Co., Ltd. Company Information
Table 146. Innovent Biologics (Suzhou) Co., Ltd. Description and Business Overview
Table 147. Innovent Biologics (Suzhou) Co., Ltd. Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Innovent Biologics (Suzhou) Co., Ltd. Anticancer Injection Product
Table 149. Innovent Biologics (Suzhou) Co., Ltd. Recent Developments/Updates
Table 150. Yifan Pharmaceutical Company Information
Table 151. Yifan Pharmaceutical Description and Business Overview
Table 152. Yifan Pharmaceutical Anticancer Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Yifan Pharmaceutical Anticancer Injection Product
Table 154. Yifan Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Anticancer Injection Distributors List
Table 158. Anticancer Injection Customers List
Table 159. Anticancer Injection Market Trends
Table 160. Anticancer Injection Market Drivers
Table 161. Anticancer Injection Market Challenges
Table 162. Anticancer Injection Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anticancer Injection
Figure 2. Global Anticancer Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anticancer Injection Market Share by Type: 2024 & 2031
Figure 4. Docetaxel Injection Product Picture
Figure 5. Paclitaxel Injection Product Picture
Figure 6. Bevacizumab Injection Product Picture
Figure 7. Adalimumab Injection Product Picture
Figure 8. Rituximab Injection Product Picture
Figure 9. Others Product Picture
Figure 10. Global Anticancer Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Anticancer Injection Market Share by Application: 2024 & 2031
Figure 12. Breast Cancer
Figure 13. Stomach Cancer
Figure 14. Ovarian Cancer
Figure 15. Lung Cancer
Figure 16. Testicular Cancer
Figure 17. Cervical Cancer
Figure 18. Endometrial Cancer
Figure 19. Prostate Cancer
Figure 20. Bladder Cancer
Figure 21. Global Anticancer Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 22. Global Anticancer Injection Market Size (2020-2031) & (US$ Million)
Figure 23. Global Anticancer Injection Sales (2020-2031) & (K Units)
Figure 24. Global Anticancer Injection Average Price (US$/Unit) & (2020-2031)
Figure 25. Anticancer Injection Report Years Considered
Figure 26. Anticancer Injection Sales Share by Manufacturers in 2024
Figure 27. Global Anticancer Injection Revenue Share by Manufacturers in 2024
Figure 28. Global 5 and 10 Largest Anticancer Injection Players: Market Share by Revenue in Anticancer Injection in 2024
Figure 29. Anticancer Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 30. Global Anticancer Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 31. North America Anticancer Injection Sales Market Share by Country (2020-2031)
Figure 32. North America Anticancer Injection Revenue Market Share by Country (2020-2031)
Figure 33. United States Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Canada Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Europe Anticancer Injection Sales Market Share by Country (2020-2031)
Figure 36. Europe Anticancer Injection Revenue Market Share by Country (2020-2031)
Figure 37. Germany Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. France Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. U.K. Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Italy Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Russia Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Asia Pacific Anticancer Injection Sales Market Share by Region (2020-2031)
Figure 43. Asia Pacific Anticancer Injection Revenue Market Share by Region (2020-2031)
Figure 44. China Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Japan Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. South Korea Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. India Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Australia Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. China Taiwan Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Southeast Asia Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Latin America Anticancer Injection Sales Market Share by Country (2020-2031)
Figure 52. Latin America Anticancer Injection Revenue Market Share by Country (2020-2031)
Figure 53. Mexico Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Brazil Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Argentina Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Anticancer Injection Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Anticancer Injection Revenue Market Share by Country (2020-2031)
Figure 58. Turkey Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Saudi Arabia Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. UAE Anticancer Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Global Sales Market Share of Anticancer Injection by Type (2020-2031)
Figure 62. Global Revenue Market Share of Anticancer Injection by Type (2020-2031)
Figure 63. Global Anticancer Injection Price (US$/Unit) by Type (2020-2031)
Figure 64. Global Sales Market Share of Anticancer Injection by Application (2020-2031)
Figure 65. Global Revenue Market Share of Anticancer Injection by Application (2020-2031)
Figure 66. Global Anticancer Injection Price (US$/Unit) by Application (2020-2031)
Figure 67. Anticancer Injection Value Chain
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
